Open access
Jul 2026
EcoXAI: Autonomous Agentic Ecosystem for Explainable Artificial Intelligence and Biomedical Discovery
In the use case in drug repurposing for Alzheimer’s Disease, EcoXAI evaluated 103 drug candidates and identified 79 novel candidates whose predictive models exceeded a randomized baseline, including the CCR5 antagonist Maraviroc, whose generated hypothesis was subsequently supported by the literature.
Nicholas Matsumoto, Hyunjun Choi, P. Freda et al.
· bioRxiv · 0 citations